Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,713,138
+$4,140,602 QoQ
Shares Held
3,377,823
+16.4% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. ANNX ranks #120 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,713,138 | 3,377,823 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,572,536 | 2,902,896 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $7,432,679 | 2,436,944 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,483,455 | 2,284,773 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,332,868 | 2,245,010 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,139,681 | 2,171,478 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,690,318 | 2,143,635 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,880,592 | 1,812,366 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $10,249,414 | 1,429,486 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,186,933 | 922,232 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,075,896 | 879,617 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,109,955 | 883,510 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,490,269 | 387,083 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,923,586 | 372,067 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,251,367 | 364,299 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $926,353 | 245,717 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,404,396 | 514,431 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,517,589 | 480,208 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,910,050 | 425,043 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,133,027 | 405,732 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,081,810 | 362,134 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,223,584 | 248,645 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,920,160 | 228,917 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||